Please click here to read our COVID-19 policies and resources before your visit or appointment. X
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Pfizer Vaccine Disappoints in Kids Ages 2 to 5

Pfizer Vaccine Disappoints in Kids Ages 2 to 5

FRIDAY, Dec. 17, 2021 (HealthDay News) -- Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine failed to spur an adequate immune response in children aged 2 to 5, the companies announced Friday.

That's a setback for parents hoping to get their youngest children immunized against the new coronavirus as soon as possible.

The pediatric trials used a 3 microgram (mcg) dose of the vaccine — equivalent to about one-tenth of the dose used in adult shots. And while two 3 mcg doses produced a good immune response in babies and children between 6 months and 2 years of age — similar to that seen in people aged 16 to 25 — they failed to do so in the 2- to 5-year age group, the companies said in a statement.

The next step? Pfizer-BioNTech says they'll try a third dose to see if that produces a more robust response, but they have no plans to try any amount of vaccine above 3 mcg. Children under 5 will get the third dose two months after they've received their second.

"The goal here is to understand the potential of protection of the third dose," Jerica Pitts, a spokeswoman for Pfizer, told The New York Times. "We are studying 3 micrograms at this time."

In a conference call held Friday, Kathrin Jansen, Pfizer's head of vaccine research, said a three-dose regimen that works for all ages of kids is the goal.

There's a building consensus that three doses of vaccine, not two, offers the best defense against the new coronavirus, including newer variants such as Omicron.

Besides the ongoing trials in very young children, Pfizer-BioNTech is also conducting trials of three doses of 10 mcg of COVID vaccine (that's one-third of the dosage used in adults) in children ages 5 through 12, the companies said. They hope to complete the trials and ask for U.S. Food and Drug Administration authorization of a three-dose vaccine series in younger kids sometime in the spring of 2022.

Children aged 16 and 17 can already receive booster shots of Pfizer vaccine: The FDA authorized that last week.

There have been very rare instances of a heart condition called myocarditis observed in male adolescents and young men who've received mRNA vaccines, prompting investigation into use of lower doses in younger age groups.

More information

Find out more about COVID-19 vaccination in children at the U.S. Centers for Disease Control and Prevention.

SOURCES: Pfizer-BioNTech, statement, Dec. 17, 2021; The New York Times

Reviewed Date: --

Find a pediatrician
Infectious Diseases
Dr. Randall Fisher
Dr. Laura Sass
Health Tips
A Simple Way to Keep the Flu Away
Helping Kids Get Over their Fears
What Every Parent Should Know About Immunizations
When Can a Child Wear Contact Lenses
Quizzes
Infant Vaccine Quiz
Prevention
Prevention Guidelines for Children from Birth to Age 2
Prevention Guidelines for Men 18 to 39
Prevention Guidelines for Women 18 to 39
Prevention Guidelines for Women 40 to 49
Prevention Guidelines for Women 50-64
Prevention Guidelines for Women 65+
Diseases & Conditions
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anxiety Disorders in Children
Asthma in Children Index
Becker Muscular Dystrophy (BMD) in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Chemotherapy for Children: Side Effects
Childhood Immunizations
Diphtheria, Tetanus, and Pertussis (DTaP)
Ewing Sarcoma in Children
Firearms
Gynecological Infections
Haemophilus Influenzae Type b (Hib)
Hepatitis B Virus (HBV) in Children
Infection in Babies
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Measles, Mumps, and Rubella (MMR)
Meningitis in Children
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Osteosarcoma (Osteogenic Sarcoma) in Children
Pediatric Blood Disorders
Pneumococcal Infection in Children
Polio (IPV)
Post-Traumatic Stress Disorder (PTSD) in Children
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Television and Children
Thalassemia
The Growing Child: 2-Year-Olds
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.